Validity and reliability problems with patient global as a component of the ACR/EULAR remission criteria as used in clinical practice

Karim R. Masri, Timothy S. Shaver, Shadi H. Shahouri, Shirley Wang, James D. Anderson, Ruth E. Busch, Kaleb D Michaud, Ted R Mikuls, Liron Caplan, Frederick Wolfe

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Objective. To investigate what factors influence patient global health assessment (PtGlobal), and how those factors and the reliability of PtGlobal affect the rate, reliability, and validity of recently published American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) rheumatoid arthritis (RA) remission criteria when used in clinical practice. Methods. We examined consecutive patients with RA in clinical practice and identified 77 who met ACR/EULAR joint criteria for remission (≤ 1 swollen joint and ≤ 1 tender joint). We evaluated factors associated with a PtGlobal > 1, because a PtGlobal ≤ 1 defined ACR/EULAR remission in this group of patients who had already met ACR/EULAR joint criteria. Results. Of the 77 patients examined, only 17 (22.1%) had PtGlobal ≤ 1 and thus fully satisfied ACR/EULAR criteria. A large proportion of patients not in remission by ACR/EULAR criteria had high PtGlobal related to noninflammatory issues, including low back pain, fatigue, and functional limitations, and a number of patients clustered in the range of PtGlobal > 1 and ≤ 2. However, the minimal detectable difference for PtGlobal was 2.3. In addition, compared with a PtGlobal severity score, a PtGlobal activity score was 3.3% less likely to be abnormal (> 1). Conclusion. Noninflammatory factors contribute to the level of PtGlobal and result in the exclusion of many patients who would otherwise be in "true" remission according to the ACR/EULAR definition. Reliability problems associated with PtGlobal can also result in misclassification, and may explain the observation of low longterm remission rates in RA. As currently constituted, the use of the ACR/EULAR remission criteria in clinical practice appears to be problematic. The Journal of Rheumatology

Original languageEnglish (US)
Pages (from-to)1139-1145
Number of pages7
JournalJournal of Rheumatology
Volume39
Issue number6
DOIs
StatePublished - Jun 1 2012

Fingerprint

Rheumatology
Rheumatic Diseases
Reproducibility of Results
Joints
Rheumatoid Arthritis
Global Health
Low Back Pain

Keywords

  • Reliability
  • Remission
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Cite this

Masri, K. R., Shaver, T. S., Shahouri, S. H., Wang, S., Anderson, J. D., Busch, R. E., ... Wolfe, F. (2012). Validity and reliability problems with patient global as a component of the ACR/EULAR remission criteria as used in clinical practice. Journal of Rheumatology, 39(6), 1139-1145. https://doi.org/10.3899/jrheum.111543

Validity and reliability problems with patient global as a component of the ACR/EULAR remission criteria as used in clinical practice. / Masri, Karim R.; Shaver, Timothy S.; Shahouri, Shadi H.; Wang, Shirley; Anderson, James D.; Busch, Ruth E.; Michaud, Kaleb D; Mikuls, Ted R; Caplan, Liron; Wolfe, Frederick.

In: Journal of Rheumatology, Vol. 39, No. 6, 01.06.2012, p. 1139-1145.

Research output: Contribution to journalArticle

Masri, Karim R. ; Shaver, Timothy S. ; Shahouri, Shadi H. ; Wang, Shirley ; Anderson, James D. ; Busch, Ruth E. ; Michaud, Kaleb D ; Mikuls, Ted R ; Caplan, Liron ; Wolfe, Frederick. / Validity and reliability problems with patient global as a component of the ACR/EULAR remission criteria as used in clinical practice. In: Journal of Rheumatology. 2012 ; Vol. 39, No. 6. pp. 1139-1145.
@article{6bdd4273d1a046d0932e9ee1d0aae218,
title = "Validity and reliability problems with patient global as a component of the ACR/EULAR remission criteria as used in clinical practice",
abstract = "Objective. To investigate what factors influence patient global health assessment (PtGlobal), and how those factors and the reliability of PtGlobal affect the rate, reliability, and validity of recently published American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) rheumatoid arthritis (RA) remission criteria when used in clinical practice. Methods. We examined consecutive patients with RA in clinical practice and identified 77 who met ACR/EULAR joint criteria for remission (≤ 1 swollen joint and ≤ 1 tender joint). We evaluated factors associated with a PtGlobal > 1, because a PtGlobal ≤ 1 defined ACR/EULAR remission in this group of patients who had already met ACR/EULAR joint criteria. Results. Of the 77 patients examined, only 17 (22.1{\%}) had PtGlobal ≤ 1 and thus fully satisfied ACR/EULAR criteria. A large proportion of patients not in remission by ACR/EULAR criteria had high PtGlobal related to noninflammatory issues, including low back pain, fatigue, and functional limitations, and a number of patients clustered in the range of PtGlobal > 1 and ≤ 2. However, the minimal detectable difference for PtGlobal was 2.3. In addition, compared with a PtGlobal severity score, a PtGlobal activity score was 3.3{\%} less likely to be abnormal (> 1). Conclusion. Noninflammatory factors contribute to the level of PtGlobal and result in the exclusion of many patients who would otherwise be in {"}true{"} remission according to the ACR/EULAR definition. Reliability problems associated with PtGlobal can also result in misclassification, and may explain the observation of low longterm remission rates in RA. As currently constituted, the use of the ACR/EULAR remission criteria in clinical practice appears to be problematic. The Journal of Rheumatology",
keywords = "Reliability, Remission, Rheumatoid arthritis",
author = "Masri, {Karim R.} and Shaver, {Timothy S.} and Shahouri, {Shadi H.} and Shirley Wang and Anderson, {James D.} and Busch, {Ruth E.} and Michaud, {Kaleb D} and Mikuls, {Ted R} and Liron Caplan and Frederick Wolfe",
year = "2012",
month = "6",
day = "1",
doi = "10.3899/jrheum.111543",
language = "English (US)",
volume = "39",
pages = "1139--1145",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "6",

}

TY - JOUR

T1 - Validity and reliability problems with patient global as a component of the ACR/EULAR remission criteria as used in clinical practice

AU - Masri, Karim R.

AU - Shaver, Timothy S.

AU - Shahouri, Shadi H.

AU - Wang, Shirley

AU - Anderson, James D.

AU - Busch, Ruth E.

AU - Michaud, Kaleb D

AU - Mikuls, Ted R

AU - Caplan, Liron

AU - Wolfe, Frederick

PY - 2012/6/1

Y1 - 2012/6/1

N2 - Objective. To investigate what factors influence patient global health assessment (PtGlobal), and how those factors and the reliability of PtGlobal affect the rate, reliability, and validity of recently published American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) rheumatoid arthritis (RA) remission criteria when used in clinical practice. Methods. We examined consecutive patients with RA in clinical practice and identified 77 who met ACR/EULAR joint criteria for remission (≤ 1 swollen joint and ≤ 1 tender joint). We evaluated factors associated with a PtGlobal > 1, because a PtGlobal ≤ 1 defined ACR/EULAR remission in this group of patients who had already met ACR/EULAR joint criteria. Results. Of the 77 patients examined, only 17 (22.1%) had PtGlobal ≤ 1 and thus fully satisfied ACR/EULAR criteria. A large proportion of patients not in remission by ACR/EULAR criteria had high PtGlobal related to noninflammatory issues, including low back pain, fatigue, and functional limitations, and a number of patients clustered in the range of PtGlobal > 1 and ≤ 2. However, the minimal detectable difference for PtGlobal was 2.3. In addition, compared with a PtGlobal severity score, a PtGlobal activity score was 3.3% less likely to be abnormal (> 1). Conclusion. Noninflammatory factors contribute to the level of PtGlobal and result in the exclusion of many patients who would otherwise be in "true" remission according to the ACR/EULAR definition. Reliability problems associated with PtGlobal can also result in misclassification, and may explain the observation of low longterm remission rates in RA. As currently constituted, the use of the ACR/EULAR remission criteria in clinical practice appears to be problematic. The Journal of Rheumatology

AB - Objective. To investigate what factors influence patient global health assessment (PtGlobal), and how those factors and the reliability of PtGlobal affect the rate, reliability, and validity of recently published American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) rheumatoid arthritis (RA) remission criteria when used in clinical practice. Methods. We examined consecutive patients with RA in clinical practice and identified 77 who met ACR/EULAR joint criteria for remission (≤ 1 swollen joint and ≤ 1 tender joint). We evaluated factors associated with a PtGlobal > 1, because a PtGlobal ≤ 1 defined ACR/EULAR remission in this group of patients who had already met ACR/EULAR joint criteria. Results. Of the 77 patients examined, only 17 (22.1%) had PtGlobal ≤ 1 and thus fully satisfied ACR/EULAR criteria. A large proportion of patients not in remission by ACR/EULAR criteria had high PtGlobal related to noninflammatory issues, including low back pain, fatigue, and functional limitations, and a number of patients clustered in the range of PtGlobal > 1 and ≤ 2. However, the minimal detectable difference for PtGlobal was 2.3. In addition, compared with a PtGlobal severity score, a PtGlobal activity score was 3.3% less likely to be abnormal (> 1). Conclusion. Noninflammatory factors contribute to the level of PtGlobal and result in the exclusion of many patients who would otherwise be in "true" remission according to the ACR/EULAR definition. Reliability problems associated with PtGlobal can also result in misclassification, and may explain the observation of low longterm remission rates in RA. As currently constituted, the use of the ACR/EULAR remission criteria in clinical practice appears to be problematic. The Journal of Rheumatology

KW - Reliability

KW - Remission

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=84861838244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861838244&partnerID=8YFLogxK

U2 - 10.3899/jrheum.111543

DO - 10.3899/jrheum.111543

M3 - Article

C2 - 22589262

AN - SCOPUS:84861838244

VL - 39

SP - 1139

EP - 1145

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 6

ER -